Vitiligo is an autoimmune condition that affects melanocytes. This application note highlights the challenges of current treatment and intradermal injection techniques, and introduces VAX-ID as a precise, easy-to-use solution for intradermal delivery.
This document includes:
- An overview of vitiligo and current treatment challenges
- The limitations of the Mantoux technique
- How VAX-ID enables accurate intradermal delivery and treatment approaches for vitiligo
Read more here
